DiaSorin to Buy Covid-19 Test-Maker Luminex for $1.8 Billion

(Bloomberg) -- Italian diagnostics company DiaSorin SpA agreed to acquire Luminex Corp. for about $1.8 billion, gaining the maker of Covid-19 testing kits and a greater foothold in the U.S. market. DiaSorin agreed to pay $37 a share in the all-cash transaction, according to a statement Sunday. That’s about 12%...